Identification of early diagnosis markers of lung adenocarcinoma based on co-expression similarity, and constructing method of risk prediction model
A technology for early diagnosis and risk prediction, applied in the field of lung adenocarcinoma prediction, can solve problems such as the inability to meet the early diagnosis of lung adenocarcinoma
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0052] The experimental methods in the following examples are conventional methods unless otherwise specified, and the involved experimental reagents and materials are conventional biochemical reagents and materials unless otherwise specified.
[0053] 1. Data reshaping and grouping
[0054] We first group the lung cancer data according to the clinical information of the samples, and the clinical grading information of each sample, namely phaseI, phaseII, phaseIII, phaseIV. According to the sample grouping, we divided the data into four parts, and it can be considered that the malignancy of lung cancer increases approximately linearly with the increase of phase. The original downloaded data of GSE20189 downloaded from GEO database includes 22277 genes and 162 samples. After comparison with clinical information, there were 81 samples in the control control group (marked as control), 28 samples from early phase I patients (marked as early phase), and 53 samples from middle and ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com